Supplementary Figure 3 from Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines

Authors :: James W. Hodge
Alfredo A. Molinolo
Lauren M. Lepone
Italia Grenga
Michael A. Coplin
Renee N. Donahue
Benedetto Farsaci
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Effect of sunitinib or sorafenib in combination with rMVATwist- TRICOM vaccine on tumor compactness in the 4T1 breast cancer model.

Full Text Access

Tools